Lantz Financial LLC Amgen Inc Transaction History

Lantz Financial LLC

$351 Million
Q3 2024

A detailed history of Lantz Financial LLC transactions in Amgen Inc stock. As of the latest transaction made, Lantz Financial LLC holds 1,574 shares of AMGN stock, worth $416,307. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,574

Previous 1,779 11.52%

Holding current value

$416,307

Previous $555,000 8.65%

% of portfolio

0.14%

Previous 0.18%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $63,422 - $69,162	-205 Reduced 11.52%	1,574 $507,000
Q2 2024 Jul 10, 2024	BUY	$262.75 - $319.31 $22,859 - $27,779	87 Added 5.14%	1,779 $555,000
Q1 2024 Apr 10, 2024	SELL	$268.87 - $324.56 $4,570 - $5,517	-17 Reduced 0.99%	1,692 $481,000
Q4 2023 Jan 12, 2024	SELL	$255.7 - $288.46 $103,814 - $117,114	-406 Reduced 19.2%	1,709 $492,000
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $20,990 - $26,060	96 Added 4.75%	2,115 $568,000
Q2 2023 Jul 12, 2023	BUY	$214.27 - $253.37 $88,707 - $104,895	414 Added 25.79%	2,019 $448,000
Q1 2023 Apr 10, 2023	BUY	$225.79 - $275.2 $53,060 - $64,672	235 Added 17.15%	1,605 $388,000
Q4 2022 Jan 23, 2023	SELL	$229.03 - $291.01 $99,857 - $126,880	-436 Reduced 24.14%	1,370 $0
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $47,136 - $53,161	210 Added 13.16%	1,806 $407,000
Q2 2022 Jul 29, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.62%	1,596 $388,000
Q1 2022 May 05, 2022	BUY	$219.27 - $242.57 $19,515 - $21,588	89 Added 5.87%	1,606 $388,000
Q4 2021 Jan 19, 2022	BUY	$198.88 - $227.6 $42,560 - $48,706	214 Added 16.42%	1,517 $341,000
Q3 2021 Oct 14, 2021	BUY	$212.27 - $248.7 $70,261 - $82,319	331 Added 34.05%	1,303 $277,000
Q1 2021 Apr 19, 2021	BUY	$221.91 - $258.6 $4,216 - $4,913	19 Added 1.99%	972 $242,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $8,006 - $9,533	37 Added 4.04%	953 $219,000
Q3 2020 Oct 09, 2020	BUY	$234.65 - $260.95 $2,111 - $2,348	9 Added 0.99%	916 $233,000
Q2 2020 Jul 22, 2020	SELL	$197.81 - $242.74 $35,407 - $43,450	-179 Reduced 16.48%	907 $214,000
Q1 2020 Apr 10, 2020	SELL	$182.24 - $241.7 $8,018 - $10,634	-44 Reduced 3.89%	1,086 $220,000
Q4 2019 Jan 17, 2020	BUY	$189.21 - $243.2 $213,807 - $274,816	1,130 New	1,130 $272,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lantz Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lantz Financial LLC with notifications on news.

Account

Lantz Financial LLC Amgen Inc Transaction History